nondiabetic controls Search Results


90
MBL Life science nondiabetic control wt mice
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Nondiabetic Control Wt Mice, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic control wt mice/product/MBL Life science
Average 90 stars, based on 1 article reviews
nondiabetic control wt mice - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GemPharmatech Co Ltd db/db and nondiabetic db/m control mice
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Db/Db And Nondiabetic Db/M Control Mice, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/db/db and nondiabetic db/m control mice/product/GemPharmatech Co Ltd
Average 90 stars, based on 1 article reviews
db/db and nondiabetic db/m control mice - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Charles River Laboratories nondiabetic male wistar rats
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Nondiabetic Male Wistar Rats, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic male wistar rats/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
nondiabetic male wistar rats - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MBL Life science nondiabetic control mbl/dko mice
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Nondiabetic Control Mbl/Dko Mice, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic control mbl/dko mice/product/MBL Life science
Average 90 stars, based on 1 article reviews
nondiabetic control mbl/dko mice - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GemPharmatech Co Ltd diabetic db/db mice and the littermate nondiabetic db/+ controls
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Diabetic Db/Db Mice And The Littermate Nondiabetic Db/+ Controls, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/diabetic db/db mice and the littermate nondiabetic db/+ controls/product/GemPharmatech Co Ltd
Average 90 stars, based on 1 article reviews
diabetic db/db mice and the littermate nondiabetic db/+ controls - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Envigo nondiabetic controls
Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), <t>nondiabetic</t> control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).
Nondiabetic Controls, supplied by Envigo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic controls/product/Envigo
Average 90 stars, based on 1 article reviews
nondiabetic controls - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Charles River Laboratories db/m (congenic nondiabetic littermates, n = 6) control mice
Average systemic and ocular parameters in db/db and <t>db/m</t> mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared <t>with</t> <t>nondiabetic</t> db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.
Db/M (Congenic Nondiabetic Littermates, N = 6) Control Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/db/m (congenic nondiabetic littermates, n = 6) control mice/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
db/m (congenic nondiabetic littermates, n = 6) control mice - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Dawley Inc male nondiabetic sprague-dawley (sd) control rats
Average systemic and ocular parameters in db/db and <t>db/m</t> mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared <t>with</t> <t>nondiabetic</t> db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.
Male Nondiabetic Sprague Dawley (Sd) Control Rats, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/male nondiabetic sprague-dawley (sd) control rats/product/Dawley Inc
Average 90 stars, based on 1 article reviews
male nondiabetic sprague-dawley (sd) control rats - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Taconic Biosciences male bks.cg-m-leprdb/leprdb diabetic (db/db) and nondiabetic heterozygous controls (db/)
Average systemic and ocular parameters in db/db and <t>db/m</t> mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared <t>with</t> <t>nondiabetic</t> db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.
Male Bks.Cg M Leprdb/Leprdb Diabetic (Db/Db) And Nondiabetic Heterozygous Controls (Db/), supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/male bks.cg-m-leprdb/leprdb diabetic (db/db) and nondiabetic heterozygous controls (db/)/product/Taconic Biosciences
Average 90 stars, based on 1 article reviews
male bks.cg-m-leprdb/leprdb diabetic (db/db) and nondiabetic heterozygous controls (db/) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Jackson Laboratory nondiabetic lean heterozygote (db/ ) controls
Average systemic and ocular parameters in db/db and <t>db/m</t> mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared <t>with</t> <t>nondiabetic</t> db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.
Nondiabetic Lean Heterozygote (Db/ ) Controls, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic lean heterozygote (db/ ) controls/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
nondiabetic lean heterozygote (db/ ) controls - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GemPharmatech Co Ltd nondiabetic db/m controls (bks.cg-m+/+leprdb/j
Average systemic and ocular parameters in db/db and <t>db/m</t> mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared <t>with</t> <t>nondiabetic</t> db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.
Nondiabetic Db/M Controls (Bks.Cg M+/+Leprdb/J, supplied by GemPharmatech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nondiabetic db/m controls (bks.cg-m+/+leprdb/j/product/GemPharmatech Co Ltd
Average 90 stars, based on 1 article reviews
nondiabetic db/m controls (bks.cg-m+/+leprdb/j - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), nondiabetic control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).

Journal: Journal of Diabetes Research

Article Title: Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

doi: 10.1155/2017/6368780

Figure Lengend Snippet: Kidney-to-body weight ratio, albumin-to-creatinine ratio, and kidney glomerulus estimation. (a) Kidney-to-body weight ratio of diabetic C57BL/6J WT mice ( n = 6), nondiabetic control C57BL/6J WT mice ( n = 6), diabetic C57BL/6J MBL/DKO mice ( n = 6), and nondiabetic control C57BL/6J mice MBL/DKO ( n = 6). (b) Albumin-to-creatinine ratio (AcR) measurements at study end for WT and MBL/DKO mice. (c and d) Light microscope representation of glomerulus from diabetic C57BL/6J MBL/DKO mice (c) and nondiabetic C57BL/6J MBL/DKO control mice (d). (e) Estimation of glomerulus volume in diabetic C57BL/6J MBL/DKO mice ( n = 13) and nondiabetic control C57BL/6J MBL/DKO mice ( n = 8). Statistical tests are indicated in figure when significant ( ∗ p < 0.05, ∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001). Data is presented as mean (solid line) with SDs (whiskers).

Article Snippet: The albumin-to-creatinine ratios were significantly elevated in the diabetic mice in both the WT group, 212.7 mg/g (CI: 172.2–253.2), as compared to the nondiabetic control WT mice, 61.2 mg/g (CI: 50.2–72.1) ( p < 0.0001), and the diabetic MBL/DKO group, 150.9 mg/g (CI: 116.1–185.7) as compared to nondiabetic control MBL/DKO mice, 43.9 mg/g (CI: 27.7–60.0) ( p < 0.0001), respectively ( ).

Techniques: Control, Light Microscopy

Blood glucose and weight gain of diabetic and nondiabetic control MBL/DKO and WT C57BL/6J mice. (a and b) Blood glucose and weight measurements for diabetic mice destined to be treated with rMBL AF680 ( n = 6), diabetic mice destined to be treated with PBS ( n = 6), control mice destined to be treated with rMBL AF680 ( n = 6), and control mice destined to be treated with PBS ( n = 6). (c and d). Comparison of the development of diabetes according to rising blood glucose levels and weight gain between diabetic ( n = 6) and control ( n = 6) C57BL/6J MBL/DKO mice and diabetic ( n = 6) and control ( n = 6) C57BL/6J WT mice. Statistical tests are given in the figure when significant, and comparisons are made between STZ treated and untreated groups at study end ( ∗∗∗∗ p < 0.0001). Values are given in mean (dots) with SD (whiskers).

Journal: Journal of Diabetes Research

Article Title: Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

doi: 10.1155/2017/6368780

Figure Lengend Snippet: Blood glucose and weight gain of diabetic and nondiabetic control MBL/DKO and WT C57BL/6J mice. (a and b) Blood glucose and weight measurements for diabetic mice destined to be treated with rMBL AF680 ( n = 6), diabetic mice destined to be treated with PBS ( n = 6), control mice destined to be treated with rMBL AF680 ( n = 6), and control mice destined to be treated with PBS ( n = 6). (c and d). Comparison of the development of diabetes according to rising blood glucose levels and weight gain between diabetic ( n = 6) and control ( n = 6) C57BL/6J MBL/DKO mice and diabetic ( n = 6) and control ( n = 6) C57BL/6J WT mice. Statistical tests are given in the figure when significant, and comparisons are made between STZ treated and untreated groups at study end ( ∗∗∗∗ p < 0.0001). Values are given in mean (dots) with SD (whiskers).

Article Snippet: The albumin-to-creatinine ratios were significantly elevated in the diabetic mice in both the WT group, 212.7 mg/g (CI: 172.2–253.2), as compared to the nondiabetic control WT mice, 61.2 mg/g (CI: 50.2–72.1) ( p < 0.0001), and the diabetic MBL/DKO group, 150.9 mg/g (CI: 116.1–185.7) as compared to nondiabetic control MBL/DKO mice, 43.9 mg/g (CI: 27.7–60.0) ( p < 0.0001), respectively ( ).

Techniques: Control, Comparison

In vivo and ex vivo detection of AF680 labelled rMBL 24 hours postinjection. (a) Fluorescent and spectral unmixing images representing one mouse in each group exhibiting distribution of labelled rMBL 24 hours postinjection (dorsal view). (b) Region of interest (ROI) quantification of detected fluorescent signal from diabetic C57BL/6J MBL/DKO mice + AF680 rMBL ( n = 6), diabetic mice + PBS ( n = 6), nondiabetic mice + AF680 rMBL ( n = 6), and nondiabetic mice + PBS ( n = 6) given in average radiant efficiency. (c) Ex vivo fluorescent and spectral unmixing images representation of the left and right kidneys from one mouse in each group. (d) ROI quantification of detected fluorescence in the right and left kidneys of mice in each group as in (b) with values given in average radiant efficiency. Scale bars are given in radiant efficiency. Statistical tests are indicated in the figure when significant ( ∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). The experiment was repeated five times with comparable results.

Journal: Journal of Diabetes Research

Article Title: Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

doi: 10.1155/2017/6368780

Figure Lengend Snippet: In vivo and ex vivo detection of AF680 labelled rMBL 24 hours postinjection. (a) Fluorescent and spectral unmixing images representing one mouse in each group exhibiting distribution of labelled rMBL 24 hours postinjection (dorsal view). (b) Region of interest (ROI) quantification of detected fluorescent signal from diabetic C57BL/6J MBL/DKO mice + AF680 rMBL ( n = 6), diabetic mice + PBS ( n = 6), nondiabetic mice + AF680 rMBL ( n = 6), and nondiabetic mice + PBS ( n = 6) given in average radiant efficiency. (c) Ex vivo fluorescent and spectral unmixing images representation of the left and right kidneys from one mouse in each group. (d) ROI quantification of detected fluorescence in the right and left kidneys of mice in each group as in (b) with values given in average radiant efficiency. Scale bars are given in radiant efficiency. Statistical tests are indicated in the figure when significant ( ∗∗ p < 0.001, ∗∗∗∗ p < 0.0001). The experiment was repeated five times with comparable results.

Article Snippet: The albumin-to-creatinine ratios were significantly elevated in the diabetic mice in both the WT group, 212.7 mg/g (CI: 172.2–253.2), as compared to the nondiabetic control WT mice, 61.2 mg/g (CI: 50.2–72.1) ( p < 0.0001), and the diabetic MBL/DKO group, 150.9 mg/g (CI: 116.1–185.7) as compared to nondiabetic control MBL/DKO mice, 43.9 mg/g (CI: 27.7–60.0) ( p < 0.0001), respectively ( ).

Techniques: In Vivo, Ex Vivo, Fluorescence

Summarized data and statistical information of in vivo and ex vivo imaging of diabetic and  nondiabetic  mice.

Journal: Journal of Diabetes Research

Article Title: Diabetes Is Associated with Increased Autoreactivity of Mannan-Binding Lectin

doi: 10.1155/2017/6368780

Figure Lengend Snippet: Summarized data and statistical information of in vivo and ex vivo imaging of diabetic and nondiabetic mice.

Article Snippet: The albumin-to-creatinine ratios were significantly elevated in the diabetic mice in both the WT group, 212.7 mg/g (CI: 172.2–253.2), as compared to the nondiabetic control WT mice, 61.2 mg/g (CI: 50.2–72.1) ( p < 0.0001), and the diabetic MBL/DKO group, 150.9 mg/g (CI: 116.1–185.7) as compared to nondiabetic control MBL/DKO mice, 43.9 mg/g (CI: 27.7–60.0) ( p < 0.0001), respectively ( ).

Techniques: In Vivo, Ex Vivo, Imaging, Control

Average systemic and ocular parameters in db/db and db/m mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared with nondiabetic db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.

Journal: Scientific Reports

Article Title: Retinal blood flow dysregulation precedes neural retinal dysfunction in type 2 diabetic mice

doi: 10.1038/s41598-021-97651-3

Figure Lengend Snippet: Average systemic and ocular parameters in db/db and db/m mice from 8 to 20 weeks of age. Significant increases were observed in body weight ( A ) and blood glucose ( B ) in db/db mice (n = 6) compared with nondiabetic db/m mice (n = 6) by two-way repeated measures ANOVA. In contrast, no significant differences were observed in systemic blood pressure ( C ), mean arterial blood pressure ( D ), intraocular pressure ( E ), and ocular perfusion pressure ( F ) between two animal groups during follow-up period. Data are expressed as the mean ± SEM; au = arbitrary unit; *P < 0.05 between groups; NS = not significant between groups.

Article Snippet: The 7-week-old male C57BL/KsJ-db/db mice (BKS.Cg-Dock7 m +/+Lepr db /J; n = 6) and db/m (congenic nondiabetic littermates, n = 6) control mice were acquired from Charles River Laboratories JAPAN, Inc. (Yokohama, Japan) one week before the study.

Techniques: